25 December 2020
–
23
–
The COVID vaccine “Sinovac” in Turkey was 91.25% more effective than the Brazilian test at 50%.
Preliminary data from the final trials inTurkeyIndicates that the vaccine prevents diseaseCOVID-19 Developed by the Chinese company Sinovac Biotech, it had 91.25% efficiency, a much better test result. Compared with such vaccine trials in Brazil.
The researchers inBrazil The Phase 3 vaccine trial revealed on Wednesday that China’s vaccine was more than 50 percent effective, but withheld disclosure.Experimental resultsAll according to the request of the companySinovac This raises questions about the transparency of the experimental data.
Turkish researchers said yesterday there were no serious side effects. It was seen during the Sinovac vaccine trial. In addition to having one of the trial participants had allergies. The most common side effect of the vaccine is fever and mild pain. And a slight exhaustion
The vaccine trial in Turkey began on Sept. 14. And more than 7,000 volunteers took part in the experiment. The latest trial results released yesterday were compiled from data from 1,322 trial participants.
Sinovac is the first vaccine manufacturer forChinaThat revealed detailsClinical trialsThe final follows rivals Pfizer, Moderna and AstraZeneca, who revealed results of a vaccine trial last month.
– .
